Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status:
Completed
Trial end date:
2016-10-22
Target enrollment:
Participant gender:
Summary
This project will assess the effectiveness of omega-3 fatty acid supplementation in
controlling asthma symptoms among obese asthmatics, and will assess if a person's genes
influence response to treatment (personalized medicine). This project may improve our ability
to treat asthma and our understanding of the link between obesity and asthma.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nemours Children's Clinic
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) Office of Dietary Supplements (ODS)